ASCO Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy Pocket Guide Cover

Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy GUIDELINES Pocket Guide

Either Endocrine-Pretreated or Hormone Receptor-Negative

Approved By

American Society of Clinical Oncology

Digital Subscription $0.00 Add to Library
Print $9.95 Add to Cart
Free Sample

CLICK HERE to receive free digital access to this pocket guide, compliments of R-Pharm-US LLC

The digital version of the Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy GUIDELINES Pocket Guide contains all the same great information found in the pocket guide, and can be accessed on mobile devices and online:

  • Price: FREE
    • Subscribe to additional guideline titles for discounted rates
  • Includes automatic updates during the term of your subscription
  • Supported platforms
    • iPhone and iPad
    • Android phones and tablets
    • Online (internet connection required)
  • Content on the Guideline Central mobile app accessible without an internet connection
    • Access to additional guideline summaries, clinical calculators, and more

For mobile access, download the free app from the App Store or Google Play and use the same email address and password as the website to login.

For individual use only; contact us for group and site licenses.

For individual use only; contact us for group and site licenses.

The Metastatic HER2-Negative Breast Cancer – Chemo- and Targeted Therapy Pocket Guide is based on the latest guidelines of the American Society of Clinical Oncology and was developed with their collaboration. It contains graded recommendations for management of either endocrine-pretreated or hormone receptor-negative metastatic breast cancer including a table of targeted therapies and two management algorithms.

  • Multifold
  • 8 Pages
  • 80# Diamond Silk Cover with Satin Aqueous Coating
  • 4.25″ x 7.25″
  • Introduction
  • Table
    • Targeted Therapies for Metastatic (or locally advanced) Breast Cancer
  • Figures
    • Management of Metastatic HR-positive Breast Cancer
    • Management of Metastatic Triple Negative Breast Cancer

Founded in 1964, the American Society of Clinical Oncology is the world's leading professional organization for physicians and oncology professionals caring for people with cancer.

  • Guideline Pricing

  • Single Title
    $4.99 / year
  • Any 5 Titles
    $23.99 / year
  • Any 10 Titles
    $41.99 / year
  • Any 35 Titles
    $74.99 / year
  • All Available Titles
    $169.99 / year

To get started, log in or create your free account Create Account